Allied and RioCan Provide Office Leasing Update for The Well

(TSX:AP.UN),(TSX:AP-UN),(TSX:REI.UN),(TSX:REI-UN), TORONTO, Nov. 18, 2025 (GLOBE NEWSWIRE) — Allied Properties Real Estate Investment Trust (“Allied”) (TSX: “AP.UN”) and RioCan Real Estate Investment Trust (“RioCan”) (TSX: “REI.UN”) today provided an office leasing update for The Well in Toronto. A Canadian company has agreed to lease 124,235 square feet of office space on the third through sixth […]

HCW Biologics Announces Initiation of First-In-Human Clinical Trial to Evaluate HCW9302 in an Autoimmune Disease

(NASDAQ:HCWB), First Patient Dosed at The Ohio State University Wexner Medical Center in this Multi-Center Trial Active component of HCW9302 is interleukin-2 — cytokine that maintains proper numbers and functions of regulatory T cells to control excessive inflammation Gateway to development of a first-in-kind immunotherapeutic for autoimmune and pro-inflammatory diseases MIRAMAR, Fla., Nov. 18, 2025

Ecora Resources PLC Announces Director Share Dealings in Company

LONDON, UK / ACCESS Newswire / November 18, 2025 / Ecora (LSE:ECOR)(TSX:ECOR)(OTCQX:ECRAF) ("Ecora" or the "Company") has received notification of the following transaction by CH Invest GmbH, a Person Closely Associated ("PCA") with Ms. Christine Coignard, Non-Executive Director of Ecora. On 14 November 2025, CH Invest GmbH acquired 11,400 ordinary shares of 2 pence each

QuickLogic eFPGA Hard IP Selected by Chipus for 12 nm High Performance Data Center ASIC

Selection underscores QuickLogic's ability to deliver flexible, silicon-proven IP that reduces ASIC risk and shortens design cycles for commercial applications QuickLogic Corporation (NASDAQ: QUIK), a developer of embedded FPGA (eFPGA) Hard IP and ruggedized FPGAs, announced today that its eFPGA Hard IP was selected by Chipus for a high performance data center production ASIC that

Solver Releases Analysis Agent Powered by Solver Copilot

With early access for select partners and customers, Analysis Agent is just one part of Solver's AI-first initiative Solver, an AI-accelerated xFP&A software company, has released its Analysis Agent, advancing the company's AI-first initiative powered by Solver Copilotto drive innovation across the Solver solution. Originally announced summer 2025, the AI-first initiativeempowers key stakeholders in various

Study: Mortgage Refinances Have Significant Fraud Risks

Fraud and forgery claims tied to refinance transactions have risen considerably in recent years, representing over 40% of all title insurer losses and expenses, according to a new study released today by global consulting and actuarial firm Milliman Inc. The study,commissioned by the American Land Title Association (ALTA), also shows that the average cost for

Levi & Korsinsky Announces an Investigation on Behalf of Akebia Therapeutics, Inc. (AKBA) Shareholders Who May Have Been Affected by Fraud

NEW YORK, NY / ACCESS Newswire / November 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Akebia Therapeutics, Inc. ("Akebia Therapeutics, Inc.") (NASDAQ:AKBA) concerning possible violations of federal securities laws. On October 29, 2025, Akebia announced that it will not pursue the VALOR trial for Vafseo label expansion

Allied and RioCan Provide Office Leasing Update for The Well

Allied and RioCan Provide Office Leasing Update for The Well GlobeNewswire November 18, 2025 TORONTO, Nov. 18, 2025 (GLOBE NEWSWIRE) — Allied Properties Real Estate Investment Trust (“Allied”) (TSX: “AP.UN”) and RioCan Real Estate Investment Trust (“RioCan”) (TSX: “REI.UN”) today provided an office leasing update for The Well in Toronto. A Canadian company has agreed

HCW Biologics Announces Initiation of First-In-Human Clinical Trial to Evaluate HCW9302 in an Autoimmune Disease

HCW Biologics Announces Initiation of First-In-Human Clinical Trial to Evaluate HCW9302 in an Autoimmune Disease GlobeNewswire November 18, 2025 First Patient Dosed at The Ohio State University Wexner Medical Center in this Multi-Center Trial Active component of HCW9302 is interleukin-2 — cytokine that maintains proper numbers and functions of regulatory T cells to control excessive

Integer Holdings Corporation Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations – ITGR

NEW YORK, NY / ACCESS Newswire / November 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Integer Holdings Corporation ("Integer Holdings Corporation") (NYSE:ITGR) concerning possible violations of federal securities laws. On October 23, 2025, Integer reported its third quarter fiscal 2025 results "in line with [their] expectations," but

Scroll to Top